BRIEF—Takeda earns 38 billion yen pay-out from property disposal

As it goes about raising money to pay for the $62 billion takeover of rare diseases specialist Shire, Takeda has announced a plan to sell of property assets.

The Japanese drugmaker has established a subsidiary called Takeda Pharmaceutical Real Estate, to which it is disposing of real estate through an absorption-type company split and share transfer.

Among the 21 assets being transferred is the Takeda Osaka Headquarters. The drugmaker will record a gain of around 38 billion yen ($350 million) as a result of the transfer in the second half of fiscal year 2018.

Takeda will continue its business at these locations as it does currently.